SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442130
Filing Date
2013-11-14
Accepted
2013-11-14 16:16:47
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d598297d10q.htm 10-Q 627387
2 EX-31.1 d598297dex311.htm EX-31.1 5344
3 EX-31.2 d598297dex312.htm EX-31.2 6233
4 EX-32.1 d598297dex321.htm EX-32.1 3854
5 EX-32.2 d598297dex322.htm EX-32.2 3825
  Complete submission text file 0001193125-13-442130.txt   4566822

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sphs-20130930.xml EX-101.INS 547797
7 XBRL TAXONOMY EXTENSION SCHEMA sphs-20130930.xsd EX-101.SCH 54555
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20130930_cal.xml EX-101.CAL 73954
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20130930_def.xml EX-101.DEF 117897
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20130930_lab.xml EX-101.LAB 382461
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20130930_pre.xml EX-101.PRE 267594
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 131220217
SIC: 2834 Pharmaceutical Preparations